Short answer
Hims & Hers Health, Inc. (HIMS) filed an 8-K current report with the SEC on November 9, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Andrew Huberman appointed as tenth director, effective November 4, 2026, but does not qualify as NYSE-independent.
Hims & Hers Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Andrew Huberman appointed as tenth director, effective November 4, 2026, but does not qualify as NYSE-independent
- Board role paired with two-year advisory agreement, $3.5M annual cash fee plus up to $1M annually for paid advertising videos
- Scicomm Media podcast marketing agreement: up to three years, $5M annual fee, with Huberman’s interest valued at approximately $2.1M annually
- Director compensation: $50,000 annual cash retainer and $250,000 annual equity award, prorated through the 2027 annual meeting
- Related-party arrangements create governance and cost scrutiny, with Huberman receiving substantial compensation from Hims-linked agreements
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Hims & Hers Health, Inc. 8-K filings
Get the next HIMS 8-K as it lands
Follow HIMS for push alerts, or ask the research agent what this filing means.